In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively suppresses production of the virus in chronically infected cells, and prevents viral rebound, even when those infected cells are subjected to vigorous stimulation.
The study, led by TSRI Associate Professor Susana Valente, was published online Oct. 17 before print in the journal Cell Reports.
“No other anti-retroviral used in the clinic today is able to completely suppress viral production in infected cells in vivo,” Valente said. “When combining this drug with the standard cocktail of anti-retrovirals used to suppress infection in humanized mouse models of HIV-1 infection, our study found a drastic reduction in virus RNA present—it is really the proof-of-concept for a ‘functional cure.’”
Valente, a pioneer in this new approach, calls it “Block-and-Lock”—the approach blocks reactivation of the virus in cells, even during treatment interruptions, and locks HIV into durable state of latency.
Valente and her colleagues use a derivative of a natural compound called didehydro-Cortistatin A (dCA), which blocks replication in HIV-infected cells by inhibiting the viral transcriptional activator, called Tat, halting viral production, reactivation and replenishment of the latent viral reservoir.
“Combining dCA with anti-retroviral therapy accelerates HIV-1 suppression and prevents viral rebound after treatment interruption, even during strong cellular activation,” Valente said. “It’s important to note that our study uses the maximum tolerable dose of the drug—with virtually no side effects.”
The scientists studied the combination therapy in a mouse model of HIV latency and persistence. Once the combined treatment regimen was halted, viral rebound was delayed up to 19 days, compared with just seven days in mouse models receiving only anti-retroviral treatment.
“This demonstrates the potential of ‘block-and-lock’ strategies,” said TSRI Research Associate Cari F. Kessing, co-first author of the study. “This study shows that a ‘functional cure’ approach can succeed in reducing residual virus in the blood during anti-retroviral treatment and limiting viral rebound during treatment interruption.”
“In half of the dCA treated mice, the virus was undetectable for 16 days after all treatment was halted,” said the University of North Carolina’s Christopher Nixon, another first author.
“We blocked Tat, and the cell’s machinery did the rest,” said TSRI Research Associate Chuan Li, a coauthor of the study. “The result was that the HIV promoter becomes repressed.”
Valente pointed out that the animal models were exposed to just a single month of treatment. “That’s a relatively short period of time,” she said. “We think longer treatments will result in longer, or even permanent, rebound delays. The question is how long? We’re studying that now.”
Because any viral rebound of HIV comes with a host of adverse effects, Valente noted, blocking that rebound would automatically reduce those effects.
“This is the only class of drugs that stops infected cells from making viruses outright,” said Valente. “All current antivirals work later in the viral lifecycle, so only a HIV transcriptional inhibitor like dCA can stop the side effects of low-level virus production.”
The Latest on: HIV
- China says tests of possibly tainted medical product show no HIV on February 7, 2019 at 1:14 am
BEIJING (Reuters) - China is investigating a manufacturer of medical products following reports that it sold human immunoglobulin for intravenous injection that had possibly been contaminated with HIV ... […]
- China says tests on plasma products negative for HIV on February 7, 2019 at 12:58 am
Chinese investigators said Thursday tests on a batch of a plasma product feared to have been contaminated with HIV have turned up negative for the virus that causes AIDS. The result appears to ... […]
- Trump Wants to End HIV Within 10 Years. Here's What That Would Take, According to Experts on February 6, 2019 at 5:14 pm
About 1.1 million Americans currently live with HIV, and approximately 40,000 are infected each year, according to federal data. But in his State of the Union address, President Donald Trump promised ... […]
- China investigating treatment possibly tainted with HIV, reports say on February 6, 2019 at 4:14 pm
Health officials in China are investigating a batch of blood plasma treatments that were reportedly infected with HIV. China’s National Health Commission released a statement on Tuesday instructing “m... […]
- Scientists kick the tires on Trump's plan to tackle HIV on February 6, 2019 at 3:35 pm
In his State of the Union address on 5 February, President Donald Trump committed to eliminating HIV in the United States by 2030. Many researchers applauded the sentiment but are sceptical that the a... […]
- How realistic is Trump’s pledge to end HIV in the U.S.? on February 6, 2019 at 3:30 pm
In his State of the Union address, President Trump promised that his administration would try to end the transmission of HIV/AIDS in the U.S. William Brangham learns more from Jon Cohen of Science Mag... […]
- Trump can’t eliminate HIV without protecting Obamacare on February 6, 2019 at 11:47 am
Robert Bonacci, MD, MPH is a resident physician in Global Health Equity and Internal Medicine at Brigham and Women’s Hospital in Boston, MA. February 6 at 2:39 PM Watching President Trump’s State of t... […]
- HIV drug could treat Alzheimer's, age-associated disorders on February 6, 2019 at 11:41 am
Researchers have found that blocking retrotransposon activity with a generic HIV/AIDS medication significantly reduces age-related inflammation in old mice and senescent human cells, providing hope fo... […]
- U.S. to target 48 counties as part of Trump push to eradicate HIV on February 6, 2019 at 10:35 am
Feb. 6 (UPI) --President Donald Trump during his state of the union speech on Tuesday announced his intention to end the HIV epidemic in the United States over the next decade. Following Trump's annou... […]
- Halting U.S. HIV Epidemic By 2030: Difficult But Doable on February 6, 2019 at 10:34 am
Trump administration health officials are spelling out their ambitious plan to stop the spread of HIV in the U.S. within the next 10 years. The plan would target 48 counties where the rate of HIV spre... […]
via Google News and Bing News